WARRANT AGREEMENTWarrant Agreement • May 1st, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 1st, 2017 Company Industry JurisdictionWARRANT AGREEMENT, dated as of February 16, 2017 (this “Agreement”), by and among Immunomedics, Inc., a Delaware corporation (the “Company”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation (the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • February 16th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 16th, 2017 Company Industry JurisdictionWARRANT AGREEMENT, dated as of February 16, 2017 (this “Agreement”), by and among Immunomedics, Inc., a Delaware corporation (the “Company”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation (the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • October 12th, 2016 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 12th, 2016 Company Industry JurisdictionWARRANT AGREEMENT, dated as of October 11, 2016 (the “Agreement”), by and among Immunomedics, Inc., a Delaware corporation (the “Company”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation (the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • July 29th, 2016 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2016 Company Industry JurisdictionWARRANT AGREEMENT, dated as of , 2016 (the “Agreement”), by and among Argos Therapeutics, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (the “Trust Company” and collectively with Computershare, “Warrant Agent”).